106 related articles for article (PubMed ID: 28762513)
1. Differential expression of two genes Oct-4 and MUC5AC associates with poor outcome in patients with gastric cancer.
Javanbakht M; Akhavanmoghadam J; Talaei AJ; Aghyani M; Mozafari M; Khedmat L; Mohebbi M
Clin Exp Pharmacol Physiol; 2017 Nov; 44(11):1099-1105. PubMed ID: 28762513
[TBL] [Abstract][Full Text] [Related]
2. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
[TBL] [Abstract][Full Text] [Related]
3. The changes in MUC5AC expression in gastric cancer before and after Helicobacter pylori eradication.
Shi D; Qiu XM; Yan XJ
Clin Res Hepatol Gastroenterol; 2014 Apr; 38(2):235-40. PubMed ID: 23910060
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of Muc5AC in gastric cancer: A meta-analysis.
Zhang CT; He KC; Pan F; Li Y; Wu J
World J Gastroenterol; 2015 Sep; 21(36):10453-60. PubMed ID: 26420972
[TBL] [Abstract][Full Text] [Related]
6. Effects of Helicobacter pylori infection on MUC5AC protein expression in gastric cancer.
Shi D; Qiu XM; Bao YF
Future Oncol; 2013 Jan; 9(1):115-20. PubMed ID: 23252568
[TBL] [Abstract][Full Text] [Related]
7. Role of MUC1 and MUC5AC expressions as prognostic indicators in gastric carcinomas.
Wang JY; Chang CT; Hsieh JS; Lee LW; Huang TJ; Chai CY; Lin SR
J Surg Oncol; 2003 Aug; 83(4):253-60. PubMed ID: 12884239
[TBL] [Abstract][Full Text] [Related]
8. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
9. Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.
Ide M; Kato T; Ogata K; Mochiki E; Kuwano H; Oyama T
Ann Surg Oncol; 2012 Oct; 19(11):3506-14. PubMed ID: 22695933
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
11. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival.
El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM
J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of aberrant Arpin expression in gastric cancer.
Li T; Zheng HM; Deng NM; Jiang YJ; Wang J; Zhang DL
World J Gastroenterol; 2017 Feb; 23(8):1450-1457. PubMed ID: 28293092
[TBL] [Abstract][Full Text] [Related]
13. Hath1 up-regulates gastric mucin gene expression in gastric cells.
Sekine A; Akiyama Y; Yanagihara K; Yuasa Y
Biochem Biophys Res Commun; 2006 Jun; 344(4):1166-71. PubMed ID: 16647036
[TBL] [Abstract][Full Text] [Related]
14. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
17. Oct4, a novel marker for human gastric cancer.
Chen Z; Xu WR; Qian H; Zhu W; Bu XF; Wang S; Yan YM; Mao F; Gu HB; Cao HL; Xu XJ
J Surg Oncol; 2009 Jun; 99(7):414-9. PubMed ID: 19347886
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
Xiong ZF; Xiao H; Tan YS
Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Kong D; Su G; Zha L; Zhang H; Xiang J; Xu W; Tang Y; Wang Z
Med Oncol; 2014 Aug; 31(8):130. PubMed ID: 25037576
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of FOXC1 correlates with poor prognosis in gastric cancer patients.
Xu Y; Shao QS; Yao HB; Jin Y; Ma YY; Jia LH
Histopathology; 2014 Jun; 64(7):963-70. PubMed ID: 24329718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
